Compass Pathways PLC

5Y6

Company Profile

  • Business description

    Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

  • Contact

    33 Broadwick Street
    LondonW1F 0DQ
    GBR

    E: [email protected]

    https://compasspathways.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Care Facilities

    Fiscal Year End

    31 December 2026

    Employees

    166

Stocks News & Analysis

stocks

Is this ASX share a value trap or bargain?

Cost-cutting the priority as underlying asset values falling on deaf ears.
stocks

Goldman Sachs Earnings: Valuations remain stretched

We raise our fair value estimate for Goldman Sachs stock.
stocks

Major ASX listed miners overvalued

We’ve adjusted our fair values after updating our commodity price assumptions.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,138.6019.70-0.22%
CAC 408,038.2773.75-0.91%
DAX 4024,658.85300.21-1.20%
Dow JONES (US)49,359.3383.11-0.17%
FTSE 10010,097.8597.50-0.96%
HKSE26,487.5176.39-0.29%
NASDAQ23,515.3914.63-0.06%
Nikkei 22552,991.10592.47-1.11%
NZX 50 Index13,573.936.36-0.05%
S&P 5006,940.010.000.00%
S&P/ASX 2008,815.9020.70-0.23%
SSE Composite Index4,113.650.35-0.01%

Market Movers